Skip to content
ClinCalc Pro
Menu
Tricyclic Antidepressant (TCA)

Imipramine

Brand names: Tofranil

Imipramine is a tricyclic antidepressant used in the treatment of depression and also for nocturnal enuresis in children.

Dosing — being independently re-sourced

ClinCalc Pro is rebuilding its dose data from primary open sources — the manufacturer SmPC (eMC), the WHO Model Formulary and other official references — under clinician review. This drug's structured dose is not yet published here. Confirm all doses against the product SmPC and your local formulary before prescribing.

Clinical monograph

How it works

It inhibits the reuptake of noradrenaline and serotonin at the synaptic cleft and also has antimuscarinic, antihistaminic and alpha-adrenergic blocking actions.

Prescribing in practice

  • Tricyclic antidepressants are dangerous in overdose, causing cardiac arrhythmias, seizures and coma, so consider toxicity risk in patients at risk of self-harm and limit quantities supplied.
  • Antimuscarinic and cardiovascular effects make it unsuitable in recent myocardial infarction, arrhythmias and severe cardiac disease, and it should be used with caution in the elderly.
  • When used for enuresis in children, dosing must follow a children's formulary and avoid the doses used for depression.

Monitoring

Monitor mood, suicidal ideation (particularly early in treatment and in younger patients), cardiac status and antimuscarinic side effects.

Counselling the patient

  • Explain that full antidepressant benefit may take several weeks.
  • Do not stop the medicine abruptly, as withdrawal effects can occur.
  • Report worsening mood, suicidal thoughts, palpitations or difficulty passing urine.

Evidence & guidelines

Imipramine is one of the original tricyclic antidepressants with long-established efficacy in depression; NICE recommends caution owing to its toxicity in overdose relative to newer agents.

Reference: NICE CG111 (Nocturnal Enuresis); Drug verified in RxNorm (NLM); confirm dosing against the manufacturer SPC (eMC). Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.